Ardolino Cancer Immunology Lab

ILC2s in cancer: good, bad, or stay tuned?

Sox10-Deficient Drug-Resistant Melanoma Cells Are Refractory to Oncolytic RNA Viruses

A New Functional Screening Platform Identifies Colistin Sulfate as an Enhancer of Natural Killer Cell Cytotoxicity

Immunotherapy for sarcomas: new frontiers and unveiled opportunities

Muscle-specific deletion of SLK/Stk2 enhances p38 activity and myogenesis in mdx mice

NK cells acquire PD-1 from the membrane of tumor cells

Is innate immunity our best weapon for flattening the curve?

Loss of the Ste20-like kinase induces a basal/stem-like phenotype in HER2-positive breast cancers

The two-faces of NK cells in oncolytic virotherapy

Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies

Killers 2.0: NK cell therapies at the forefront of cancer control

Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade